DGAP-Adhoc: Bernhard Giessel takes over from Karl-Heinz

PlasmaSelect AG / Change of Personnel

14.08.2008 

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

Munich, 14.08.2008  Bernhard Giessel (48), appointed Member of the
Management Board of PlasmaSelect AG in December 2007, will take over as CEO
of the company with effect from 15 August 2008, retaining responsibility
for finance, sales, purchasing, logistics and materials management. This
change of CEO marks a milestone in the companys strategic realignment.
Karl-Heinz Riggers (52), who, when CEO, was responsible for PlasmaSelect
AGs value-generating restructuring, will retire from the Management Board
after nine years to support the development of the Aquaworx holding and
identify potential new acquisitions in the field of Health Care  New
Technologies. The vacant position on the Management Board will be filled
over the medium term by an expert from the field of investment
management/mergers & acquisitions management.

---------------------------------------------------------------------------

Information and Explaination of the Issuer to this News:

Coompany sets course for development as a technology-focused investment
holding company; Karl-Heinz Riggers to take over strategic development of
Aquaworx AG

Munich, 14.08.2008 Bernhard Giessel (48), appointed Member of the
Management Board of PlasmaSelect AG in December 2007, will take over as CEO
of the company with effect from 15 August 2008, retaining responsibility
for finance, sales, purchasing, logistics and materials management.  This
change of CEO marks a milestone in the companys strategic realignment.
Previously an operating holding company in the healthcare field,
PlasmaSelect has undergone gradual conversion into an investment holding
company, setting a course for sustainable profitable growth. The
transformation was launched by the highly profitable spin-off of business
divisions in highly consolidated low-growth and low-margin markets,
yielding over EUR 80 million in recent years (EUR 20 million of which was
accounted for by the earn-out agreement still in force). Karl-Heinz Riggers
(52), who as CEO was responsible for PlasmaSelect AGs value-generating
restructuring, will retire from the Management Board after nine years and
devote himself to providing more effective support for business
opportunities arising from the acquisition of Aquaworx AG, and particularly
to examining the option of an IPO in the next 2  3 years. Thanks to his
outstanding industry contacts, Karl-Heinz Riggers will also take over the
task of identifying potential new acquisitions in the field of Health Care
 New Technologies. The vacant position on the Managing Board will be
filled over the medium term by an expert from the field of investment
management/mergers & acquisitions management.

'During my time as CEO of PlasmaSelect AG, I launched the necessary
structural and strategic measures to reposition the company as a
technology-focused investment holding company, and thus oriented towards
long-term growth markets such as water treatment', explains departing CEO
Karl-Heinz Riggers. 'Now the time has come to hand the wheel over to
Bernhard Giessel, who possesses an impressive range of expertise in the
field of investment and turnaround management. I look forward to taking up
the exciting challenge of driving strategic development at Aquaworx and
paving the way for an IPO.'

Explaining PlasmaSelects future strategy, designated CEO Bernhard Giessel
comments, 'With great determination, Karl-Heinz Riggers achieved impressive
results in a very short time with respect to the repositioning of
PlasmaSelect, and set the company on a new course.  Now my activities will
focus on advancing the development of the remaining associated companies to
deliver double-digit sales revenues and sustained market positions. In
addition, we will concentrate on acquisitions in long-term growth markets.
The sale of business divisions has brought PlasmaSelect sufficient liquid
funds, which we will invest wisely to generate dynamic, profitable growth
and thus fundamentally increase shareholder value.'

Phases of the repositioning process  buy-and-build strategy
After conducting in-depth analyses, in the first restructuring phase
PlasmaSelect AG decided to spin off divisions in consolidated markets, such
as the capital-intensive generics division, and low-margin activities. In
the second phase from late 2007, production processes and production
process costs of the remaining divisions in the field of infusion and
irrigation solutions will be subjected to ongoing review to identify
potential areas of optimization, and will undergo appropriate restructuring
to enable action to be rapidly implemented. Parallel to these developments,
Karl-Heinz Riggers and new PlasmaSelect CEO Bernhard Giessel have
supervised the implementation of Phase 3, in which 30% of shares and 50.1%
of voting rights of Aquaworx AG were purchased on 29 May 2008. Aquaworx AG
develops and produces patent-pending technologies for water and liquid
disinfection and filtration, thus contributing significantly to sustainable
resource management. The platform technology is based on a brilliant
combination of UV rays and ultrasound in a single system, effectively
eliminating bacteria and preventing their reproduction.

'Our investment in Aquaworx AG is representative of the new positioning of
PlasmaSelect AG as an investment holding company ', adds Bernhard Giessel.
'We pursue a buy-and-build (hold or sell) strategy, in which PlasmaSelect
takes over the management of a company or selected positions and supports
the company in its business development and restructuring by providing
centralized corporate services. Our objective is to establish a balanced
portfolio of long-term investments and spin-offs of new divisions.'


PlasmaSelect AG
Founded in 1998 as a specialist in the sale of infusion and irrigation
solutions and complementary medical products, today PlasmaSelect AG is an
innovative investment holding company on the healthcare  new technologies
market. The holding currently comprises six operating subsidiaries with a
total of almost 300 staff worldwide. In fiscal 2007 (as of 30 November
2007) the company reported consolidated sales of EUR 56.2 million.

PlasmaSelect AG is listed on the Regulated Market (Prime Standard) of the
Frankfurt Stock Exchange (securities ID 547 180). For more information
please see www.plasmaselect.de
DGAP 14.08.2008 
---------------------------------------------------------------------------
Language:     English
Issuer:       PlasmaSelect AG
              Pettenkoferstraße 22
              80336 München
              Deutschland
Phone:        +49 (0)89 810 29-0
Fax:          +49 (0)89 810 29-111
E-mail:       info@plasmaselect.de
Internet:     www.plasmaselect.de
ISIN:         DE0005471809
WKN:          547180
Listed:       Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr
              in Berlin, Stuttgart, München, Hamburg, Düsseldorf
End of News                                     DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Bernhard Giessel takes over from Karl-Heinz Riggers as CEO of PlasmaSelect AG
